OtherBASIC SCIENCE INVESTIGATIONS
Radioimmunotherapy with Anti-CD66 Antibody: Improving the Biodistribution Using a Physiologically Based Pharmacokinetic Model
Peter Kletting, Thomas Kull, Donald Bunjes, Bettina Mahren, Markus Luster, Sven N. Reske and Gerhard Glatting
Journal of Nuclear Medicine March 2010, 51 (3) 484-491; DOI: https://doi.org/10.2967/jnumed.109.067546
Peter Kletting
Thomas Kull
Donald Bunjes
Bettina Mahren
Markus Luster
Sven N. Reske
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 51, Issue 3
March 2010
Radioimmunotherapy with Anti-CD66 Antibody: Improving the Biodistribution Using a Physiologically Based Pharmacokinetic Model
Peter Kletting, Thomas Kull, Donald Bunjes, Bettina Mahren, Markus Luster, Sven N. Reske, Gerhard Glatting
Journal of Nuclear Medicine Mar 2010, 51 (3) 484-491; DOI: 10.2967/jnumed.109.067546
Radioimmunotherapy with Anti-CD66 Antibody: Improving the Biodistribution Using a Physiologically Based Pharmacokinetic Model
Peter Kletting, Thomas Kull, Donald Bunjes, Bettina Mahren, Markus Luster, Sven N. Reske, Gerhard Glatting
Journal of Nuclear Medicine Mar 2010, 51 (3) 484-491; DOI: 10.2967/jnumed.109.067546